Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
GRADE evidence profile for participants in randomised controlled trials (RCTs) compared with eligible non-participants who received similar treatment
|
Outcome |
No of comparisons |
Design |
Study limitations |
Consistency |
Directness* |
No of patients in RCT |
No. of patients outside RCT |
Relative effect (95% CI) |
Overall quality |
|
Dichotomous |
73 |
Observational |
No serious limitations† |
Important inconsistencies‡ |
Direct |
30 458 |
19 640 |
0.94 (0.87 to 1.02) |
Very low |
|
Continuous |
18 |
Observational |
No serious limitations† |
No important inconsistencies |
Direct |
713 |
764 |
0.01 ( |
Low |
|
Mortality |
32 |
Observational |
No serious limitations† |
Important inconsistencies‡ |
Direct |
26 406 |
16 609 |
1.00 (0.91 to 1.09) |
Very low |
GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:14.
*Studies vary widely in terms of participants, interventions, and outcome measures; directness (applicability) of overall results to any specific trial is difficult to assess, particularly in light of unexplained heterogeneity of results.
†Although many studies were poorly controlled, differences in risk of bias did not seem to be related to differences in results, and overall results are consistent with results for studies without serious limitations.
‡Important, unexplained, statistically significant heterogeneity.
§Standardised mean difference (95% confidence interval).